Rottier P, Emile G, Johnson A, Levy C, Allouache D, Hrab I
Front Oncol. 2023; 12:1105587.
PMID: 36741710
PMC: 9893782.
DOI: 10.3389/fonc.2022.1105587.
Alshamsan B, Alshibany A, Elshenawy M, Badran A, Elhassan T, Ajarim D
Cancer Manag Res. 2022; 13:9411-9420.
PMID: 35002318
PMC: 8721024.
DOI: 10.2147/CMAR.S343549.
Wanifuchi-Endo Y, Kondo N, Dong Y, Fujita T, Asano T, Hisada T
Oncol Lett. 2022; 23(2):60.
PMID: 34992692
PMC: 8721851.
DOI: 10.3892/ol.2021.13178.
Korobeinikova E, Ugenskiene R, Insodaite R, Rudzianskas V, Jaselske E, Poskiene L
Oncol Lett. 2020; 19(6):3687-3700.
PMID: 32391092
PMC: 7204491.
DOI: 10.3892/ol.2020.11521.
Retel Helmrich I, Lingsma H, Turgeon A, Yamal J, Steyerberg E
J Neurotrauma. 2020; 38(18):2502-2513.
PMID: 32316847
PMC: 8403181.
DOI: 10.1089/neu.2019.6708.
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.
Sekula P, Mallett S, Altman D, Sauerbrei W
PLoS One. 2017; 12(6):e0178531.
PMID: 28614415
PMC: 5470677.
DOI: 10.1371/journal.pone.0178531.
The association between dietary vitamin A intake and pancreatic cancer risk: a meta-analysis of 11 studies.
Zhang T, Chen H, Qin S, Wang M, Wang X, Zhang X
Biosci Rep. 2016; 36(6).
PMID: 27756825
PMC: 5293573.
DOI: 10.1042/BSR20160341.
DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
Tang Q, Holland-Letz T, Slynko A, Cuk K, Marme F, Schott S
Oncotarget. 2016; 7(39):64191-64202.
PMID: 27577081
PMC: 5325435.
DOI: 10.18632/oncotarget.11640.
Association between telomere length and survival in cancer patients: a meta-analysis and review of literature.
Xu X, Qu K, Pang Q, Wang Z, Zhou Y, Liu C
Front Med. 2016; 10(2):191-203.
PMID: 27185042
DOI: 10.1007/s11684-016-0450-2.
The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis.
Mao Y, Qu Q, Chen X, Huang O, Wu J, Shen K
PLoS One. 2016; 11(4):e0152500.
PMID: 27073890
PMC: 4830515.
DOI: 10.1371/journal.pone.0152500.
The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
Korobeinikova E, Myrzaliyeva D, Ugenskiene R, Raulinaityte D, Gedminaite J, Smigelskas K
BMC Genet. 2015; 16:70.
PMID: 26112140
PMC: 4482272.
DOI: 10.1186/s12863-015-0234-8.
Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.
Tang L, Jin X, Yang H, He M, Chang H, Shao Z
BMC Cancer. 2015; 15:201.
PMID: 25885213
PMC: 4389816.
DOI: 10.1186/s12885-015-1207-z.
GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma.
Feld F, Nagel P, Weissinger S, Welke C, Stenzinger A, Moller P
Oncotarget. 2015; 6(6):4516-26.
PMID: 25595905
PMC: 4414208.
DOI: 10.18632/oncotarget.2799.
The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
Mao Y, Qu Q, Zhang Y, Liu J, Chen X, Shen K
PLoS One. 2014; 9(12):e115103.
PMID: 25501357
PMC: 4264870.
DOI: 10.1371/journal.pone.0115103.
Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.
Schroder C, Milde-Langosch K, Gebauer F, Schmid K, Mueller V, Wirtz R
J Cancer Res Clin Oncol. 2013; 139(10):1745-55.
PMID: 23996067
DOI: 10.1007/s00432-013-1496-z.
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer.
Schutze D, Milde-Langosch K, Witzel I, Rody A, Karn T, Schmidt M
J Cancer Res Clin Oncol. 2013; 139(5):747-54.
PMID: 23358720
DOI: 10.1007/s00432-013-1378-4.
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.
Muller V, Riethdorf S, Rack B, Janni W, Fasching P, Solomayer E
Breast Cancer Res. 2012; 14(4):R118.
PMID: 22894854
PMC: 3680931.
DOI: 10.1186/bcr3243.
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.
Witzel I, Loibl S, von Minckwitz G, Eidtmann H, Fehm T, Khandan F
Br J Cancer. 2012; 107(6):956-60.
PMID: 22892393
PMC: 3464767.
DOI: 10.1038/bjc.2012.353.
Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.
Weissenstein U, Schumann A, Reif M, Link S, Toffol-Schmidt U, Heusser P
BMC Cancer. 2012; 12:206.
PMID: 22646670
PMC: 3404911.
DOI: 10.1186/1471-2407-12-206.
Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival.
Sung H, Jeon S, Lee K, Han S, Song M, Choi J
BMC Cancer. 2012; 12:195.
PMID: 22639842
PMC: 3487887.
DOI: 10.1186/1471-2407-12-195.
